Methods

Published on 24 Nov 2023

Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes

in Drugs Outcomes Research and Policies

Karolina Zebrowska
Rosa C. Banuelos
Evelyn J. Rizzo
Kathy W. Belk
Gary Schneider
Koen Degeling

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1249998

1,641 views
2 citations

Review

Published on 23 Nov 2023

Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges

in Drugs Outcomes Research and Policies

Xin Chen
Ruyue He
Xinyi Chen
Liyun Jiang
Fei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1261312

2,399 views
2 citations

Original Research

Published on 22 Nov 2023

Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity

in Drugs Outcomes Research and Policies

Wenyun Yang
Ruyue He
Yuehan Sun
Fangrong Yan
Fei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266322

1,242 views

Correction

Published on 22 Nov 2023

Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study

in Drugs Outcomes Research and Policies

Geok Ying Chun
Nurul Ain Mohd Tahir
Farida Islahudin
Veena Selvaratnam
Shu Chuen Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1336072

505 views

Original Research

Published on 21 Nov 2023

Healthcare professional perspectives on medication challenges in the post-stroke patient

in Drugs Outcomes Research and Policies

Shauna Bell
Helen Kelly
Eva Hennessy
Margaret Bermingham
Jennifer Raymy O’Flynn
Laura J. Sahm

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266277

1,921 views
1 citation

Original Research

Published on 21 Nov 2023

Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis

in Drugs Outcomes Research and Policies

Han Xie
Xinyi Chen
Min Xue
Huaying Li
Yonghan Ge
Weihong Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1268793

975 views

Editorial

Published on 21 Nov 2023

Editorial: Effective methods to promote appropriate use of medicines

in Drugs Outcomes Research and Policies

Yen-Ming Huang
Yuki Kondo
Tomoya Tachi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1331906

1,346 views

Correction

Published on 17 Nov 2023

Corrigendum: Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

in Drugs Outcomes Research and Policies

Xikui Lu
Lu Zhang
Hangxing Huang
Xiangping Wu
Zhenting Wang
Ling Huang
Jingyang Li
Huimin Yu
Hongyan Zhang
Jian Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1327256

770 views

Systematic Review

Published on 17 Nov 2023

Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis

in Drugs Outcomes Research and Policies

Jiyifan Li
Chenyang Zhu
Jingru Liang
Jiarong Hu
Haiyang Liu
Zihan Wang
Ruifang Guan
Junwei Chow
Shiwei Yan
Longzhou Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1303694

3,126 views
6 citations

Systematic Review

Published on 16 Nov 2023

Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations

in Drugs Outcomes Research and Policies

Jamie Elvidge
Gareth Hopkin
Nithin Narayanan
David Nicholls
Dalia Dawoud

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1291164

1,615 views

Systematic Review

Published on 16 Nov 2023

Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

in Drugs Outcomes Research and Policies

Mohammed M. Alsultan
Abdullah K. Alahmari
Mansour A. Mahmoud
Ziyad S. Almalki
Wafa Alzlaiq
Faisal Alqarni
Fahad Alsultan
Nehad Jaser Ahmed
Ahmed O. Alenazi
Lucas Scharf

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1276491

2,779 views
1 citation

Mini Review

Published on 14 Nov 2023

Optimization of inpatient medication administration among persons with Parkinson’s disease: recommendations on pharmacy technology and workflow

in Drugs Outcomes Research and Policies

Jeryl Ritzi T. Yu
Brent S. Sokola
Benjamin L. Walter

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1254757

2,379 views

Original Research

Published on 14 Nov 2023

Exploring the antecedents of AI adoption for effective HRM practices in the Indian pharmaceutical sector

in Drugs Outcomes Research and Policies

Manisha Goswami
Supriya Jain
Tabish Alam
Ahmed Farouk Deifalla
Adham E. Ragab
Rohit Khargotra

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1215706

4,739 views
5 citations

Brief Research Report

Published on 14 Nov 2023

Medication economic burden of antidepressant non-adherence in Spain

in Drugs Outcomes Research and Policies

Eduardo Gutiérrez-Abejón
M. Aránzazu Pedrosa-Naudín
Diego Fernández-Lázaro
F. Javier Alvarez

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266034

1,975 views

Original Research

Published on 13 Nov 2023

Drug information-seeking behaviour among Jordanian physicians: a cross-sectional study

in Drugs Outcomes Research and Policies

Sura Al Zoubi
Lobna Gharaibeh
Enas A. Amaireh
Ghaidaa S. Khlaifat
Haya M. Diab Khalayla
Sajedah N. Obeid
Khaled A. Abukhalaf
Amer M. AlSalamat
Zaha Al-Zoubi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1264794

1,547 views

Original Research

Published on 13 Nov 2023

Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov

in Drugs Outcomes Research and Policies

Zelei Dai
Nian Li
Jun Wang
Chenfeng Tan
Yonggang Zhang
Lei Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1212813

1,545 views
1 citation

Navigation group

Articles

Quantifying the impact of novel metastatic cancer therapies on health inequalities in survival outcomes

Optimizing dose-schedule regimens with bayesian adaptive designs: opportunities and challenges

Enhancing phase I dose-finding trials design through dynamic borrowing information and handling late-onset toxicity

Corrigendum: Drug-related problems among transfusion-dependent thalassemia patients: a real-world evidence study

Healthcare professional perspectives on medication challenges in the post-stroke patient

Construction of a pharmaceutical care mode for cancer pain patients in primary care based on the Delphi method: an effective analysis

Editorial: Effective methods to promote appropriate use of medicines

Corrigendum: Therapy by physician–pharmacist combination and economic returns for cancer pain management in China: a cost-effectiveness analysis

Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis

Diagnostics and treatments of COVID-19: two-year update to a living systematic review of economic evaluations

Effectiveness and safety of edoxaban versus warfarin in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies

Optimization of inpatient medication administration among persons with Parkinson’s disease: recommendations on pharmacy technology and workflow

Exploring the antecedents of AI adoption for effective HRM practices in the Indian pharmaceutical sector

Medication economic burden of antidepressant non-adherence in Spain

Drug information-seeking behaviour among Jordanian physicians: a cross-sectional study

Anti-PD-1/PD-L1 for nasopharyngeal carcinoma: a comprehensive analysis of registered trials on ClinicalTrials.gov